Evidence map›Paper›PMID 37940844›Full record

ArticleBMC genomic data2023

Molecular characterization and phylogenetic analysis of the first Corynebacterium rouxii strains isolated in Brazil: a recent member of Corynebacterium diphtheriae complex.

Juliana Nunes Ramos, Max Roberto Batista Araújo, Paulo Victor Pereira Baio, Lincoln Oliveira Sant'Anna, João Flávio Carneiro Veras, Érica Miranda Damásio Vieira, Mireille Ângela Bernardes Sousa, Carlos Henrique Camargo, Cláudio Tavares Sacchi, Karoline Rodrigues Campos and 6 more

Open access · goldAbstract read
In one paragraph

Article in BMC genomic data, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Quinolone Resistance and Zoonotic Potential ofAntibiotics (Basel, Switzerland) · 2025
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 1 country.

Juliana Nunes RamosLaboratory of Diphtheria and Corynebacteria of Clinical Relevance, Department of Microbiology, Immunology and Parasitology, Rio de Janeiro State University, Rio de Janeiro, Brazil.
Max Roberto Batista AraújoOperational Technical Nucleus, Hermes Pardini Institute, Microbiology, Belo Horizonte, Brazil.
Paulo Victor Pereira BaioArmy Chemical and Pharmaceutical Laboratory, Ministry of Defense, Brasília, Brazil.
Lincoln Oliveira Sant'AnnaLaboratory of Diphtheria and Corynebacteria of Clinical Relevance, Department of Microbiology, Immunology and Parasitology, Rio de Janeiro State University, Rio de Janeiro, Brazil.
João Flávio Carneiro VerasLaboratório Interdisciplinar de Pesquisas Médicas (LIPMED) - Instituto Oswaldo Cruz - Fundação Oswaldo Cruz (Fiocruz), Av. Brasil, 4365. Pavilhão Cardoso Fontes, 1°. andar, sala 17. Manguinhos, Rio de Janeiro, CEP:21040-900, Brazil.
Érica Miranda Damásio VieiraLaboratório Interdisciplinar de Pesquisas Médicas (LIPMED) - Instituto Oswaldo Cruz - Fundação Oswaldo Cruz (Fiocruz), Av. Brasil, 4365. Pavilhão Cardoso Fontes, 1°. andar, sala 17. Manguinhos, Rio de Janeiro, CEP:21040-900, Brazil.
Mireille Ângela Bernardes SousaOperational Technical Nucleus, Hermes Pardini Institute, Microbiology, Belo Horizonte, Brazil.
Carlos Henrique CamargoCenter of Bacteriology, Adolfo Lutz Institute, Secretary of Health of the State of São Paulo, São Paulo, Brazil.
Cláudio Tavares SacchiStrategic Laboratory, Adolfo Lutz Institute, Secretary of Health of the State of São Paulo, São Paulo, Brazil.
Karoline Rodrigues CamposStrategic Laboratory, Adolfo Lutz Institute, Secretary of Health of the State of São Paulo, São Paulo, Brazil.
Marlon Benedito Nascimento SantosStrategic Laboratory, Adolfo Lutz Institute, Secretary of Health of the State of São Paulo, São Paulo, Brazil.
Sérgio BokermannCenter of Bacteriology, Adolfo Lutz Institute, Secretary of Health of the State of São Paulo, São Paulo, Brazil.
Luige Biciati AlvimOperational Technical Nucleus, Research and Development, Hermes Pardini Institute, Belo Horizonte, Brazil.
Louisy Sanches Dos SantosLaboratory of Diphtheria and Corynebacteria of Clinical Relevance, Department of Microbiology, Immunology and Parasitology, Rio de Janeiro State University, Rio de Janeiro, Brazil.
Ana Luiza de Mattos-GuaraldiLaboratory of Diphtheria and Corynebacteria of Clinical Relevance, Department of Microbiology, Immunology and Parasitology, Rio de Janeiro State University, Rio de Janeiro, Brazil.
Verônica Viana VieiraLaboratório Interdisciplinar de Pesquisas Médicas (LIPMED) - Instituto Oswaldo Cruz - Fundação Oswaldo Cruz (Fiocruz), Av. Brasil, 4365. Pavilhão Cardoso Fontes, 1°. andar, sala 17. Manguinhos, Rio de Janeiro, CEP:21040-900, Brazil. vieira@ioc.fiocruz.br.
Instituto Adolfo Lutz · BRUniversidade do Estado do Rio de Janeiro · BRFundação Oswaldo Cruz · BRMinistry of Defence · BR

Funding

Lacrimal Gland Repair Using Progenitor CellsR01EY026202 · NEI · SCRIPPS RESEARCH INSTITUTE, THE · PI MAKARENKOVA, HELEN P. · 2016 to 2025
$5.2M
6 · The paper itself

Abstract

backgroundCorynebacterium diphtheriae complex was formed by the species C. diphtheriae, Corynebacterium ulcerans and Corynebacterium pseudotuberculosis in the recent past. In addition to C. diphtheriae, C. ulcerans and C. pseudotuberculosis species can carry the tox gene, which encodes diphtheria toxin. Currently, three new species have been included in the complex: Corynebacterium rouxii, Corynebacterium silvaticum, and Corynebacterium belfantii. C. rouxii is derived from the ancient Belfanti biovar of C. diptheriae. We provide the complete genome sequences of two non-toxigenic strains C. rouxii isolated from a cat with a purulent infection in Brazil. The taxonomic status and sequence type, as well as the presence of resistance and virulence genes, and CRISPR-Cas system were additionally defined.

resultsThe genomes showed an average size of 2.4 Mb and 53.2% GC content, similar to the type strain of the species deposited in Genbank/NCBI. Strains were identified as C. rouxii by the rMLST database, with 95% identity. ANI and DDH in silico were consistent with values above the proposed cut-off points for species limit, corroborating the identification of the strains as C. rouxii. MLST analyses revealed a new ST, which differs from ST-537 only by the fusA allele. No horizontal transfer resistance gene was predicted in both genomes and no mutation was detected in the constitutive genes gyrA and rpoB. Some mutations were found in the seven penicillin-binding proteins (PBPs) detected. The tox gene was not found, but its regulatory gene dtxR was present. Among the predicted virulence genes are those involved in iron uptake and adherence, in addition to the DIP0733 protein involved in epithelial cell adhesion and invasion. The CRISPR-Cas type I-E system was detected in both genomes, with 16 spacer sequences each. Of them, half are unknown according to the databases used, indicating that there is an unexplored reservoir of corynebacteriophages and plasmids.

conclusionsThis is the first genomic study of C. rouxii reported in Brazil. Here we performed taxonomic analysis and the prediction of virulence factors. The genomic analyses performed in this study may help to understand the potential pathogenesis of non-toxigenic C. rouxii strains.

Indexed as

Corynebacterium diphtheriaeBrazilCorynebacteriumMultilocus Sequence TypingPhylogenyCorynebacterium diphtheriae complexCorynebacterium rouxiiCRISPR-Cas systemNon-toxigenicResistance genesVirulence factors

Identifiers

PMID37940844
PMCPMC10634135
OpenAlexW4388490364

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.